These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine. Krzystanek M; Krupka-Matuszczyk I Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416 [TBL] [Abstract][Full Text] [Related]
5. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. Chakos M; Lieberman J; Hoffman E; Bradford D; Sheitman B Am J Psychiatry; 2001 Apr; 158(4):518-26. PubMed ID: 11282684 [TBL] [Abstract][Full Text] [Related]
6. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder. Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Cooper TB; Chakos M; Lieberman JA Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268 [TBL] [Abstract][Full Text] [Related]
7. Sequential Multiple-Assignment Randomized Trials to Compare Antipsychotic Treatments (SMART-CAT) in first-episode schizophrenia patients: Rationale and trial design. Li X; Guo X; Fan X; Feng T; Wang C; Yao Z; Xu X; Chen Z; Wang H; Xie S; He J; Zhuo K; Xiang Q; Cen H; Wang J; Smith RC; Jin H; Keshavan MS; Marder SR; Davis JM; Jiang K; Xu Y; Liu D Schizophr Res; 2021 Apr; 230():87-94. PubMed ID: 33279374 [TBL] [Abstract][Full Text] [Related]
8. Clozapine: a comparison with other novel antipsychotics. Fleischhacker WW J Clin Psychiatry; 1999; 60 Suppl 12():30-4. PubMed ID: 10372608 [TBL] [Abstract][Full Text] [Related]
9. Mid-term and long-term efficacy and effectiveness of antipsychotic medications for schizophrenia: a data-driven, personalized clinical approach. Glick ID; Correll CU; Altamura AC; Marder SR; Csernansky JG; Weiden PJ; Leucht S; Davis JM J Clin Psychiatry; 2011 Dec; 72(12):1616-27. PubMed ID: 22244023 [TBL] [Abstract][Full Text] [Related]
10. Management of treatment-resistant patients with schizophrenia. Marder SR J Clin Psychiatry; 1996; 57 Suppl 11():26-30. PubMed ID: 8941168 [TBL] [Abstract][Full Text] [Related]
11. Switching to Clozapine Using Immediate Versus Gradual Antipsychotic Discontinuation: A Pilot, Double-Blind, Randomized Controlled Trial. Takeuchi H; Lee J; Fervaha G; Foussias G; Agid O; Remington G J Clin Psychiatry; 2017 Feb; 78(2):223-228. PubMed ID: 28234436 [TBL] [Abstract][Full Text] [Related]
12. Aripiprazole in treatment-refractory schizophrenia. Hsu WY; Lee CI; Chiu NY; Kahn DA J Psychiatr Pract; 2009 May; 15(3):221-6. PubMed ID: 19461396 [TBL] [Abstract][Full Text] [Related]
13. Olanzapine treatment after clozapine-induced granulocytopenia in 3 patients. Swartz JR; Ananth J; Smith MW; Burgoyne KS; Gadasally R; Arai Y J Clin Psychiatry; 1999 Feb; 60(2):119-21. PubMed ID: 10084639 [TBL] [Abstract][Full Text] [Related]
14. Reversible neutropenia with olanzapine following clozapine-induced neutropenia. Thangadurai P; Jyothi KS; Gopalakrishnan R; Kuruvilla A; Jacob KS Am J Psychiatry; 2006 Jul; 163(7):1298. PubMed ID: 16816247 [No Abstract] [Full Text] [Related]
15. Obsessive-compulsive symptoms in patients with schizophrenia: a naturalistic cross-sectional study comparing treatment with clozapine, olanzapine, risperidone, and no antipsychotics in 543 patients. Scheltema Beduin AA; Swets M; Machielsen M; Korver N; J Clin Psychiatry; 2012 Nov; 73(11):1395-402. PubMed ID: 23218156 [TBL] [Abstract][Full Text] [Related]